Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled...
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
About this item
Full title
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Current controlled trials in cardiovascular medicine, 2024-05, Vol.25 (1), p.297-1, Article 297
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
More information
Alternative Titles
Full title
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1ace9de022f048999908ece1ab83c0f4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1ace9de022f048999908ece1ab83c0f4
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-024-08146-1
